MedTech startup Janitri aims to allocate the acquired funds to scaling up its current product offering in hospitals and homes and acquiring relevant international regulatory approvals
Janitri, a medtech start-up focused on pregnancy monitoring, secured $1.1 million in pre-Series A led by iAngels-backed India Accelerator. The investment round also witnessed the participation of other investors, including C-camp, Namita Thapar, O2 angels, Ashish Kacholia, IKP and others. In their last round, Janitri was funded by the Singapore-based Pureland Venture group.
Founded in 2016, Janitri provides wearables and AI-enabled solutions for pregnancy and labor vitals monitoring. With the acquired funds, it plans to scale up its current product offering in hospitals and clinics and gain traction for early entry to home monitoring. Additionally, the medtech startup aims to acquire international regulatory approvals by 2024.
Janitri claims to have reached over 300 hospitals, 60,000 mothers and saved 5000 lives. Arun Agarwal, the founder of Janitri, said, “This space (maternal & child healthcare, medical device) needs a lot of attention, funding, and awareness to make sure no mother or newborn dies or gets life-long complications during pregnancy, labour or post-delivery.”
Mona Singh, co-founder of India Accelerator, said, “Janitri’s devices are compact and portable, making it much easier for expecting mothers to manage their pregnancy through these devices. We are confident that Janitri’s product offerings are going to be a game-changer in the market as it strives to ensure healthy pregnancy and delivery, a suitable candidate for acquisition for big players of the industry like Philips, GE or Siemens.’’
Janitri has designed a fetal-maternal monitoring system boasting automated interpretation, remote monitoring and patient comfort. The system is embedded with AI-enabled features to send automated alerts/alarms and help doctors access important patient health data and graphs to avoid complications.
The start-up marks the development of the products for each and every kind of healthcare setting, home monitoring and in transit monitoring. Based on clinical research and patented technology, Janitri has built portable and easy-to-use fetal monitoring devices and software for hospitals. It provides digital labour monitoring tools, remote data monitoring, digital case sheet generation, nurse’s application and remote access to patient data for a stress-free pregnancy.
Investor of Janitri from its Shark Tank, Season 2 journey, Namita Thapar, said, “Janitri is solving one part of the problem using wearable and AI-enabled fetal-maternal vitals monitoring solutions to prevent this mortality and morbidity. Even if it saves one life, it is worth the investment. Arun is a fantastic entrepreneur, smart, driven and with a strong sense of purpose. I’m excited to be part of his journey.”
It also unveiled Q MAS devices, which include point-of-care lifestyle monitoring products, including multifunction fingertip health monitors, mesh nebulisers, and more
The start-up will utilize the capital to develop its product portfolio, expand its team and strengthen its intellectual property
Gastroenterology and ENT were the most consulted specialties in India. Online appointments by women grew over 65 per cent in 2022 as compared to 2021